Breaking Female Hearts: The Gender Gap in Cardiovascular Research
DOI:
https://doi.org/10.17140/HROJ-3-e006Abstract
Cardiovascular disease is the biggest killer of both men and women, causing 17.5 million deaths
combined in 2012,1 which is expected to rise to 23.4 million by 2030.2 The leading cause of
death in both sexes is ischemic heart disease, with hypertensive heart disease also appearing in
the top ten and vascular complications the majority of the remainder.1 Notably, mortality rates
are increasing more rapidly in younger women compared to men.3 Given these observations, it
might be expected that our knowledge of the cardiovascular system and treatment of its disorders
would be based on studies performed on biological material and organisms of both male
and female origin, in fairly equal proportions. However, this is simply not the case. In biomedical
research, many publications do not specify the sex of the animals (presumably the reader
should assume male), and where sex is specified the majority focus on males.4 In addition,
drug studies are conducted mainly on males.5 Equal representation of men and women is also
lacking in many large-scale clinical trials4,6; somewhat surprising given that women represent a
rather significant proportion of patients undergoing treatment in the clinic.
References
World Health Organisation (WHO). Media centre. Web site. http://www.who.int/mediacentre/factsheets/en/. Accessed August 31, 2016
Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States: A policy statement from the American Heart Association. Circ: Heart Failure. 2013; 6(3): 606-619. doi: 10.1161/HHF.0b013e318291329a
Merz CNB, Andersen HS, Shufelt CL. Gender, cardiovascular disease, and the sexism of obesity. J Am CollCardiol. 2015; 66(18): 1958-1960. doi: 10.1016/j.jacc.2015.08.860
Yoon DY, Mansukhani NA, Stubbs VC, et al. Sex bias exists in basic science and translational surgical research. Surgery. 2014; 156(3): 508-516. doi: 10.1016/j.surg.2014.07.001
Klein SL, Schiebinger L, Stefanick ML, et al. Opinion: Sex inclusion in basic research drives discovery. Proc Natl Acad Sci USA. 2015; 112(17): 5257-5258. doi: 10.1073/pnas.1502843112
Ouyang P, Wenger NK, Taylor D, et al. Strategies and methods to study female-specific cardiovascular health and disease: A guide for clinical scientists. Biol Sex Differ. 2016; 7: 19. doi: 10.1186/s13293-016-0073-y
MacDonald JK, Pyle WG, Reitz CJ, et al. Cardiac contraction, calcium transients, and myofilament calcium sensitivity fluctu-ate with the estrous cycle in young adult female mice. Am J Physiol Heart Circ Physiol. 2014; 306(7): H938-H953. doi: 10.1152/ ajpheart.00730.2013
Frasier CR, Brown DA, Sloan RC, et al. Stage of the estrous cycle does not influence myocardial ischemia-reperfusion injury in rats (Rattus norvegicus). Comp Med. 2013; 63(5): 416-421.Web site. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796752/. Accessed August 31, 2016
Prendergast BJ, Onishi KG, Zucker I. Female mice liberated for inclusion in neuroscience and biomedical research. Neurosci-Biobehav Rev. 2014; 40: 1-5. doi: 10.1016/j.neubiorev.2014.01.001
Du XJ. Gender modulates cardiac phenotype development in genetically modified mice. Cardiovasc Res. 2004; 63(3): 510-519. doi: 10.1016/j.cardiores.2004.03.027
Leinwand LA. Sex is a potent modifier of the cardiovascular system. J Clin Invest. 2003; 112(3): 302-307. doi: 10.1172/ JCI200319429
Fernandez-Sola J, Nicolas-Arfelis JM. Gender differences in alcoholic cardiomyopathy. J Gend Specif Med. 2002; 5: 41-47. Web site. http://europepmc.org/abstract/med/11859686. Accessed August 31, 2016
Bell JR, Curl CL, Harding TW, et al. Male and female hypertrophic rat cardiac myocyte functional responses to ischemic stress and β-adrenergic challenge are different. Biol Sex Differ. 2016; 7: 32. doi: 10.1186/s13293-016-0084-8
Mehta LS, Beckie TM, DeVon HA, et al. Acute myocardial infarction in women. A Scientific Statement From the American Heart Association. Circulation. 2016; 134(9). doi: 10.1161/CIR.0000000000000351
Patten RD. Models of gender differences in cardiovascular disease. Drug Discov Today Dis Models. 2007; 4(4): 227-232. doi: 10.1016/j.ddmod.2007.11.002
Cung TT, Morel O, Cayla G, et al. Cyclosporine before PCI in patients with acute myocardial infarction. N Engl J Med. 2015; 373(11): 1021-1031. doi: 10.1056/NEJMoa1505489
Fiedler LR. Pharmacological agents in the clinic: Trial and error. Heart Res Open J. 2015; 2(4): 126-130. doi: 10.17140/HROJ-2-122
Redberg RF. Gender, race, and cardiac care: Why the differences? J Am CollCardiol. 2005; 26(10): 1852-1854. doi: 10.1016/j. jacc.2005.07.043
Bae S, Zhang L. Gender differences in cardioprotection against ischemia/reperfusion injury in adult rat hearts: Focus on Akt and protein kinase C signaling. J Pharmacol Exp Ther. 2005; 315(3): 1125-1135. doi: 10.1124/jpet.105.090803
Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized control trial. JAMA. 2002; 288: 321-333. doi: 10.1001/ jama.288.3.321
Clayton JA, Collins FS. Policy: NIH to balance sex in cell and animal studies. Nature. 2014; 509: 282-283. doi: 10.1038/509282a
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart fail-ure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur J Heart Fail. 2016; 18(8): 891-975. doi: 10.1093/eurheartj/ehw128
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Heart Research (HROJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.